Nighthawk Biosciences, Inc. posts annual revenue of $6.38 million in 2022

Nighthawk Biosciences, Inc. [NHWK] has reported $43.86 million loss for the fiscal year ending Dec 31, 2022.

Revenue for the year was $6.38 million with operating income of $45.69 million.

The Morrisville, North Carolina (NC)-based company operating in the pharmaceutical preparations sector with 77 employees has total shareholders equity of $73.92 million.

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.